Market Tracker

12/05 7:18am ET

Cascadian Therapeutics Inc (NASDAQ:CASC)

5.50
Delayed Data
As of Dec 02
 +0.53 / +10.66%
Today’s Change
4.89
Today|||52-Week Range
22.50
-58.71%
Year-to-Date
No recent news for Cascadian Therapeutics Inc.

Today’s Trading

Previous close4.97
Today’s open5.00
Day’s range4.97 - 5.60
Volume338,755
Average volume (3 months)114,067
Market cap$124.0M
Dividend yield--
Data as of 12/02/2016

Growth & Valuation

Earnings growth (last year)+46.88%
Earnings growth (this year)-61.76%
Earnings growth (next 5 years)+0.20%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book6.24

Competitors

 Today’s
change
Today’s
% change
AVXLAnavex Life Sciences...-0.05-1.31%
PRTOProteon Therapeutics...+0.14+1.53%
ARWRArrowhead Pharmaceut...+0.12+9.09%
CDXSCodexis Inc-0.20-4.30%
Data as of 12/02/2016

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$0.00
Annual profit (last year)-$32.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott D. Myers
Chief Operating Officer
Gary W. Christianson
Corporate headquarters
Seattle, Washington

Forecasts